Postponement of the 2020 Targeted Therapies Patient Forum in Boston

dbrock's picture
Please read the information below regarding the 2020 Targeted Therapies Patient Forum reschedule due to COVID-19.
Denise Brock, Operations Director

The health and safety of our staff, faculty and patient community is our highest priority. 


Therefore, the Global Resource for Advancing Cancer Education has made the decision to postpone our annual Targeted Therapies Forum, originally scheduled for March 28 in Boston, until early fall due to the current COVID-19 outbreak.
 

Due to travel bans and health risk concerns, rescheduling this event will enable us to ensure an experience that all participants expect and deserve in a safe environment.

We are eager to have you join us for this highly anticipated annual live and livestreamed event which features the top oncologists in their field presenting the most current and emerging information in targeted therapies and answering patient questions in real time. We will publish the specific date for the rescheduled Targeted Therapies Forum in the coming weeks. Your registration will automatically be applied to the rescheduled event; no need to re-register. 

Meanwhile, registration will remain open if you wish to join us.  As information becomes available we will notify you.  

The latest information about our Targeted Therapies Forum will always be available at www.cancergrace.org

If you have any questions regarding your registration, please email us at LiveEvent@cancerGRACE.org. Your voice matters, and we care about your feedback.

We look forward to having you join us in the fall. Until then, stay safe and healthy!

 


Join GRACE in Boston, MA  - Rescheduled date coming soon

Register Below for the GRACE 2020 Targeted Therapies Patient Forum!

This event will be held at the Boston Logan Airport Hilton, Rescheduled date TBD

For Details - Please View the full Agenda and the Faculty Information for more information! 

Register Now!  

Video Language: 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation